RxE2 Revolutionizes Clinical Trials with Groundbreaking AI-led Technology Platform and Marketplace

FARGO, N.D., Dec. 4, 2023 /PRNewswire/ — RxE2, the pioneer in pharmacy-led medical innovation, announces the launch of a groundbreaking technology platform that redefines the clinical trial landscape. RxE2 is the first technology company to seamlessly connect independent community pharmacies with the forefront of healthcare innovation, ushering in a new era of patient-centric and cost-effective clinical research. At the…

RxE2 Northstar Development Cycling

RxE2 CEO and Two-Time USA Cycling Masters Nationals Champion Gerald Finken Donates $27,500 to NorthStar Development Cycling Club

Fargo, ND, February 2, 2021— RxE2 CEO and two-time USA Cycling Masters National Cycling Champion, Gerald Finken, is once again helping young cyclists. RxE2 announced today that it will donate $27,500 to support the youth programs of the NorthStar Development Cycling Club. ‍ Mr. Finken’s current contribution will help to support the: training of young cyclists,…

RxE2 acquires Habitu

RxE2 Agrees to Acquire Habitu to Form the First AI Driven, Pharmacist-Led, Clinical Trial Platform

Fargo, ND, January 11, 2021 — RxE2, which is bringing the practice of pharmacy to clinical research, announced today it has agreed to acquire Habitu, an Israeli-based technology company.  Habitu focuses on people’s habits and behaviors to create a KyP engine enabled by artificial intelligence, improving patient outcomes by providing real time analyses of a…

RxE2 and Newdays Pharmacy Expand E2 Dispensing Service for Clinical Drug Trials to the EU and UK

E2 Dispensing is part of the RxE2’s decentralized clinical trial research platform, which makes clinical trial enrollment possible for everyone, everywhere. Fargo, North Dakota, and London, UK July 29, 2020 — RxE2 and Newdays Pharmacy have launched the first pharmacy dispensing services for clinical drug trials in the European Union and the United Kingdom. This…

RxE2 Names Tina Schlecht, Pharm. D., VP of Pharmacy Operations

Fargo, ND, July 15, 2020  —  RxE2 announced today the appointment of Tina Schlecht, Pharm. D. as the company’s Vice President of Pharmacy Operations. Tina Schlecht, Pharm. D., Vice President ofPharmacy Operations, RxE2 In this role, Dr. Schlecht will be responsible for: Onboarding new pharmacies worldwide to RxE2’s decentralized clinical research platform Overseeing the company’s…